rapt therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Brian Wong

rapt.com/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Phreesia and Sesame Workshop Win Point of Care Excellence Award for Best Unbranded Campaign

GrowGeneration Corp. (GRWG) Q4 2025 Earnings Call Transcript

SGL Carbon SE (SGLFF) Q4 2025 Earnings Call Transcript

Grupo Aeroportuario del Pacifico Announces Refinancing of Bank Loan for USD$95.5 Million

GEMI UPDATE: Hagens Berman Alerts Gemini Space Station (GEMI) Investors to Securities Class Action Following 75% Post-IPO Collapse

Goldman Sachs Replaces Big Annual Layoff With Targeted Rolling Cuts

Oil falls as U.S. weighs releasing sanctioned Iranian crude to cool prices

GEMI Investors Have Opportunity to Lead Gemini Space Station, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Exxaro Resources Limited (EXXAF) Q4 2025 Earnings Call Transcript

RCI Hospitality Holdings, Inc. (RICK) Q4 2025 Earnings Call Transcript

ROSEN, A LEADING LAW FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

OpenAI to create desktop super app, combining ChatGPT app, browser and Codex app

Oil Falls Amid Prospects of Removal of U.S. Sanctions on Iranian Oil at Sea

FiscalNote Holdings, Inc. (NOTE) Q4 2025 Earnings Call Transcript

3 Best Dividend Growth Stocks to Buy in March

Uber gave up on driverless cars. Now it's paying the price.

SNOW Investors Have Opportunity to Lead Snowflake Inc. Securities Fraud Lawsuit

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit

Dolly Varden Provides Update on Exchangeable Share Election Process

ROSEN, A LEADING LAW FIRM, Encourages PomDoctor Ltd. Investors With Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action - POM

About